AR012960A1 - Una composicion farmaceutica para utilizar en el tratamiento del sindrome de intestino irritable que comprende compuestos vainillinicos; el uso decompuestos vainillinicos, un metodo de tratamiento del sindrome de intestino irritable; un proceso para la fabricacion de dicha composicion - Google Patents
Una composicion farmaceutica para utilizar en el tratamiento del sindrome de intestino irritable que comprende compuestos vainillinicos; el uso decompuestos vainillinicos, un metodo de tratamiento del sindrome de intestino irritable; un proceso para la fabricacion de dicha composicionInfo
- Publication number
- AR012960A1 AR012960A1 ARP980102742A ARP980102742A AR012960A1 AR 012960 A1 AR012960 A1 AR 012960A1 AR P980102742 A ARP980102742 A AR P980102742A AR P980102742 A ARP980102742 A AR P980102742A AR 012960 A1 AR012960 A1 AR 012960A1
- Authority
- AR
- Argentina
- Prior art keywords
- vanillin
- compounds
- hydroxy
- treatment
- methoxyphenyl
- Prior art date
Links
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical class COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 210000000936 intestine Anatomy 0.000 title 2
- 238000000034 method Methods 0.000 title 2
- 208000011580 syndromic disease Diseases 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 abstract 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 235000012141 vanillin Nutrition 0.000 abstract 3
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 abstract 3
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- -1 vanillin compound Chemical class 0.000 abstract 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N 1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione Chemical compound C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 abstract 1
- MXXWOMGUGJBKIW-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-yl)-1-(1-piperidinyl)-1-penta-2,4-dienone Chemical compound C=1C=C2OCOC2=CC=1C=CC=CC(=O)N1CCCCC1 MXXWOMGUGJBKIW-UHFFFAOYSA-N 0.000 abstract 1
- 206010000060 Abdominal distension Diseases 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 abstract 1
- 230000003187 abdominal effect Effects 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 208000024330 bloating Diseases 0.000 abstract 1
- 235000017663 capsaicin Nutrition 0.000 abstract 1
- 229960002504 capsaicin Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 abstract 1
- 229940075559 piperine Drugs 0.000 abstract 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 abstract 1
- 235000019100 piperine Nutrition 0.000 abstract 1
- 210000000664 rectum Anatomy 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9711962.2A GB9711962D0 (en) | 1997-06-10 | 1997-06-10 | Therapeutically active compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012960A1 true AR012960A1 (es) | 2000-11-22 |
Family
ID=10813845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102742A AR012960A1 (es) | 1997-06-10 | 1998-06-10 | Una composicion farmaceutica para utilizar en el tratamiento del sindrome de intestino irritable que comprende compuestos vainillinicos; el uso decompuestos vainillinicos, un metodo de tratamiento del sindrome de intestino irritable; un proceso para la fabricacion de dicha composicion |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6201014B1 (https=) |
| EP (1) | EP0988028B1 (https=) |
| JP (1) | JP2002513418A (https=) |
| KR (1) | KR20010013618A (https=) |
| CN (1) | CN1198594C (https=) |
| AR (1) | AR012960A1 (https=) |
| AT (1) | ATE262892T1 (https=) |
| AU (1) | AU737606B2 (https=) |
| BR (1) | BR9809994A (https=) |
| CA (1) | CA2291796C (https=) |
| DE (1) | DE69822822T2 (https=) |
| GB (3) | GB9711962D0 (https=) |
| HU (1) | HUP0004245A2 (https=) |
| ID (1) | ID22878A (https=) |
| PL (1) | PL337337A1 (https=) |
| WO (1) | WO1998056356A1 (https=) |
| ZA (1) | ZA984920B (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6790207B2 (en) * | 1998-06-04 | 2004-09-14 | Curon Medical, Inc. | Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract |
| US20110071468A1 (en) * | 1998-06-04 | 2011-03-24 | Mederi Therapeutics, Inc. | Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction |
| US6802841B2 (en) * | 1998-06-04 | 2004-10-12 | Curon Medical, Inc. | Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction |
| GB9812426D0 (en) * | 1998-06-10 | 1998-08-05 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
| GB9925127D0 (en) * | 1999-10-22 | 1999-12-22 | Pharmacia & Upjohn Spa | Oral formulations for anti-tumor compounds |
| AU3582101A (en) * | 2000-03-01 | 2001-09-12 | Euro-Celtique S.A. | The treatment of functional gastrointestinal disorders |
| US6759064B2 (en) | 2001-02-22 | 2004-07-06 | Purdue Research Foundation | Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer |
| US7192612B2 (en) * | 2001-02-22 | 2007-03-20 | Purdue Research Foundation | Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer |
| US6428822B1 (en) | 2001-04-03 | 2002-08-06 | Chengzhi Life Science Company, Ltd. | Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification |
| US6682759B2 (en) * | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| US7198804B2 (en) * | 2002-04-12 | 2007-04-03 | Helixir Co., Ltd. | Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases |
| MXPA05006670A (es) | 2002-12-18 | 2005-10-19 | Algorx Pharmaceuticals Inc | Administracion de capsaicinoides. |
| US20040161481A1 (en) * | 2002-12-18 | 2004-08-19 | Algorx | Administration of capsaicinoids |
| US20050085652A1 (en) * | 2003-04-08 | 2005-04-21 | Algorx Pharmaceuticals, Inc. | Preparation and purification of synthetic capsaicin |
| US20100159000A1 (en) * | 2003-11-10 | 2010-06-24 | Lundeen Sr James E | Medicine for treating gastrointestinal disorder including fecal incontinence |
| AT413646B (de) * | 2004-04-02 | 2006-04-15 | Hammer Johann Dr | Verwendung von capsaicin und/oder capsaicinoiden |
| US20050277657A1 (en) * | 2004-06-15 | 2005-12-15 | Dusan Ninkov | Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children |
| AU2005309586A1 (en) * | 2004-11-24 | 2006-06-01 | Algorx Pharmaceuticals, Inc. | Capsaicinoid gel formulation and uses thereof |
| JP5775246B2 (ja) | 2004-12-28 | 2015-09-09 | メステックス アクチェンゲゼルシャフトＭｅｓｔｅｘ Ａｇ | 関節痛を治療する薬剤を生成するためのレシニフェラトキシン（ｒｔｘ）の使用方法および前記薬剤を適用する方法 |
| WO2008052183A2 (en) | 2006-10-27 | 2008-05-02 | Bmb Patent Holding Corporation | Therapeutic compositions and methods of treatment with capsianoside-type compounds |
| AU2008292907A1 (en) * | 2007-08-29 | 2009-03-05 | Sorbent Therapeutics, Inc. | Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
| KR20090047637A (ko) * | 2007-11-08 | 2009-05-13 | 재단법인서울대학교산학협력재단 | 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물 |
| HUP0700755A2 (en) * | 2007-11-26 | 2009-08-28 | Pannonpharma Gyogyszergyar | Pharmaceutical compositions containing capsaicionoid and non-steroidal anti-inflammatory drug |
| US8697155B2 (en) * | 2008-07-22 | 2014-04-15 | Mayo Foundation For Medical Education And Research | Treatment of obesity and related disorders |
| US20110200669A1 (en) * | 2010-02-15 | 2011-08-18 | Winston Laboratories, Inc. | Method and compositions of civamide to treat disease of the intestines |
| KR101378973B1 (ko) * | 2012-04-13 | 2014-03-28 | 한미약품 주식회사 | 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법 |
| CN103027901B (zh) * | 2012-12-11 | 2014-11-12 | 广东药学院 | 一种载辣椒素壳聚糖微球肠溶片及其制备方法 |
| US10092528B2 (en) | 2013-03-13 | 2018-10-09 | Altria Client Services Llc | Application of encapsulated capsaicin and analogues thereof for controlling calorie intake |
| US9289418B2 (en) | 2013-03-15 | 2016-03-22 | Cedars-Sinai Medical Center | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
| JP2016516717A (ja) | 2013-03-15 | 2016-06-09 | シーダーズ−サイナイ メディカル センター | メタン細菌に起因または関連する疾患および状態を診断、選択、および処置する方法 |
| JP2017509596A (ja) | 2014-01-30 | 2017-04-06 | オムニアクティブ ヘルス テクノロジーズ リミテッド | 辛味がある油性芳香性物質の組成物およびその調製方法 |
| KR102425303B1 (ko) | 2014-08-13 | 2022-07-25 | 세다르스-신나이 메디칼 센터 | 항-메탄생성 조성물 및 그것의 용도 |
| WO2016161085A1 (en) * | 2015-04-01 | 2016-10-06 | Cedars-Sinai Medical Center | Anti-methanogenic lovastatin analogs or derivatives and uses thereof |
| WO2021011002A1 (en) * | 2019-07-18 | 2021-01-21 | Dignify Therapeutics, Llc | Compositions and methods for inducing defecation |
| FI4135652T3 (fi) * | 2020-04-15 | 2025-01-21 | Gruenenthal Gmbh | Resiniferatoksiinikoostumuksia |
| AU2022207425A1 (en) * | 2021-01-15 | 2023-07-06 | Dignify Therapeutics, Llc | Compositions and methods for inducing defecation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2207705A1 (en) * | 1972-11-24 | 1974-06-21 | Marconnet Rene | Deodorisation of body odours - by liberation of odoriferous substances in the intestines |
| EP0015334B1 (en) * | 1977-08-04 | 1982-05-19 | J.B. Tillott Limited | Carminative preparations containing peppermint oil or its active components |
| US4681897A (en) * | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| HU206082B (en) * | 1988-12-23 | 1992-08-28 | Sandoz Ag | Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds |
| US5403868A (en) | 1988-12-23 | 1995-04-04 | Sandoz Ltd. | Capsaicin derivatives |
| US5063060A (en) | 1989-12-19 | 1991-11-05 | Cisco Limited Partnership | Compositions and method for treating painful, inflammatory or allergic disorders |
| DE4137540A1 (de) * | 1991-11-14 | 1993-05-19 | Steigerwald Arzneimittelwerk | Verwendung von praeparaten der curcuma-pflanzen |
| US5431914A (en) | 1992-04-17 | 1995-07-11 | Adekunle; Michael | Method of treating an internal condition by external application of capsaicin without the need for systemic absorption |
| DE4392300T1 (de) * | 1992-05-21 | 1995-12-07 | Jeff J Staggs | Therapeutische Gebräuche von beißenden Pflanzen und Ihre Verwandten Zusammensetzungen |
| US5762963A (en) * | 1995-06-07 | 1998-06-09 | Emory University | Method and compositions for controlling oral and pharyngeal pain using capsaicinoids |
| EP0839037B1 (en) * | 1995-07-14 | 2002-11-13 | Sabinsa Corporation | Bioprotectant composition, method of use and extraction process of curcuminoids |
-
1997
- 1997-06-10 GB GBGB9711962.2A patent/GB9711962D0/en active Pending
-
1998
- 1998-06-03 GB GBGB9811819.3A patent/GB9811819D0/en active Pending
- 1998-06-08 WO PCT/GB1998/001673 patent/WO1998056356A1/en not_active Ceased
- 1998-06-08 CN CNB988060469A patent/CN1198594C/zh not_active Expired - Fee Related
- 1998-06-08 CA CA002291796A patent/CA2291796C/en not_active Expired - Fee Related
- 1998-06-08 DE DE1998622822 patent/DE69822822T2/de not_active Expired - Fee Related
- 1998-06-08 US US09/445,514 patent/US6201014B1/en not_active Expired - Fee Related
- 1998-06-08 ID IDW991447A patent/ID22878A/id unknown
- 1998-06-08 HU HU0004245A patent/HUP0004245A2/hu unknown
- 1998-06-08 AU AU77829/98A patent/AU737606B2/en not_active Ceased
- 1998-06-08 GB GB9827192A patent/GB2332147B/en not_active Expired - Fee Related
- 1998-06-08 AT AT98925862T patent/ATE262892T1/de not_active IP Right Cessation
- 1998-06-08 KR KR19997011628A patent/KR20010013618A/ko not_active Withdrawn
- 1998-06-08 PL PL98337337A patent/PL337337A1/xx not_active IP Right Cessation
- 1998-06-08 BR BR9809994-9A patent/BR9809994A/pt not_active Application Discontinuation
- 1998-06-08 JP JP50108699A patent/JP2002513418A/ja not_active Ceased
- 1998-06-08 EP EP98925862A patent/EP0988028B1/en not_active Expired - Lifetime
- 1998-06-10 AR ARP980102742A patent/AR012960A1/es not_active Application Discontinuation
- 1998-06-18 ZA ZA984920A patent/ZA984920B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6201014B1 (en) | 2001-03-13 |
| ZA984920B (en) | 1999-07-01 |
| EP0988028B1 (en) | 2004-03-31 |
| PL337337A1 (en) | 2000-08-14 |
| GB2332147B (en) | 1999-10-27 |
| ATE262892T1 (de) | 2004-04-15 |
| ID22878A (id) | 1999-12-16 |
| BR9809994A (pt) | 2000-08-01 |
| KR20010013618A (ko) | 2001-02-26 |
| GB2332147A (en) | 1999-06-16 |
| EP0988028A1 (en) | 2000-03-29 |
| DE69822822D1 (de) | 2004-05-06 |
| AU7782998A (en) | 1998-12-30 |
| CN1198594C (zh) | 2005-04-27 |
| GB9711962D0 (en) | 1997-08-06 |
| CA2291796C (en) | 2008-03-25 |
| CN1259863A (zh) | 2000-07-12 |
| WO1998056356A1 (en) | 1998-12-17 |
| GB9827192D0 (en) | 1999-02-03 |
| AU737606B2 (en) | 2001-08-23 |
| CA2291796A1 (en) | 1998-12-17 |
| GB9811819D0 (en) | 1998-07-29 |
| HUP0004245A2 (hu) | 2001-08-28 |
| DE69822822T2 (de) | 2005-01-13 |
| JP2002513418A (ja) | 2002-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012960A1 (es) | Una composicion farmaceutica para utilizar en el tratamiento del sindrome de intestino irritable que comprende compuestos vainillinicos; el uso decompuestos vainillinicos, un metodo de tratamiento del sindrome de intestino irritable; un proceso para la fabricacion de dicha composicion | |
| ES2151083T3 (es) | Composiciones orales que contienen ondansetron. | |
| CO5271700A1 (es) | Composicion farmaceutica que comprende acido 3-[2,4-dimetil-5-(2-oxo-1,2-dihidro-indol-3-ilidenmetil)-1h-pirrol-3-il]-propionico, uno o mas compuestos polihidrocarbilo y un vehiculo farmaceuticamente aceptable | |
| KR970706814A (ko) | 동결 건조된 온단세트론 조성물(Freeze-Dried Ondansetron Compositions) | |
| JP2002501049A5 (https=) | ||
| ATE309206T1 (de) | Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen | |
| EA200200571A1 (ru) | Новая композиция и ее применение | |
| ES2183618T3 (es) | Formulaciones para el tratamiento del reflujo gastroesofagico. | |
| WO1996020734A3 (en) | Oral gastrointestinal x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants | |
| NO20006194D0 (no) | Farmasöytisk sammensetning for behandling av funksjonell dyspepsi og/eller irriterbar innvollssyndrom og ny anvendelse av substanser deri | |
| ATE284712T1 (de) | Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide | |
| NO20032510D0 (no) | Organiske forbindelser | |
| AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
| EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
| UY27627A1 (es) | Aza - arilpiperazinas | |
| AR029190A1 (es) | Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco | |
| IT1229568B (it) | Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico. | |
| ATE519486T1 (de) | Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer | |
| AR018197A1 (es) | Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento | |
| PE41096A1 (es) | Tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar | |
| DE602004005564D1 (de) | Pharmazeutische Zusammensetzung für Thrombinpeptidderivaten | |
| RU2210573C2 (ru) | Углеводные производные | |
| DE60042831D1 (de) | Pharmazeutisch aktive sulfonylaminosäurederivate | |
| CO5261595A1 (es) | Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium | |
| ATE400563T1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |